Literature DB >> 28237489

Expression and clinical significance of high risk human papillomavirus and invasive gene in cervical carcinoma.

Zhai Lu1, Hua Chen2, Xiao-Mei Zheng1, Man-Ling Chen1.   

Abstract

OBJECTIVE: To study the expression of E6 and E7 mRNA in high-risk human papillomavirus (HPV) HPV-18 and the relationship between the expression of invasive gene and cervical carcinoma.
METHODS: A total of 119 patients with cervical cancer, cervical erosion and cervical HPV infection who were diagnosed in our hospital were selected and randomly divided into two groups: cervical cancer group (n = 58) and non-cancerous group (n = 61). Another 60 patients with uterine leiomyoma were selected as normal control group. Detection of HPV18 E6, E7 mRNA expression and invasion, migration, proliferation inhibition genes, epithelial mesenchymal transition genes and proliferation related protein content.
RESULTS: The relative expression of E6 and E7 HPV-18 in cervical cancer group was significant higher than that in non-cancerous group and control group (mRNA) (P < 0.05). The content of TRAF6 and c-FLIP in invasive cervical cancer group was significantly higher than that in non-cancerous group and control group (P < 0.05). The mRNA content of CD44v6 and MMP-9 in cervical cancer group was significantly higher than that in non-cancerous group and control group (P < 0.05). The content of DEC-1, IKK16, MBP-1 in cervical cancer group was significant lower than that in non-cancerous group and control group (P < 0.05). The mRNA content of beta -catenin and Vimentin in cervical cancer group was significantly lower than that in non cancerous group and control group (P < 0.05). The proliferation related protein E2F1 of cervical cancer group was significantly lower than that of non-cancerous group and control group, Bmi-1 content was significantly higher than non-cancerous group and control group (P < 0.05).
CONCLUSIONS: The expression of the detection of cervical cancer in high-risk human papilloma virus HPV-18 E6 and E7 mRNA, and the invasion, migration, proliferation inhibition gene, epithelial mesenchymal transition and proliferation related gene protein content, HPV expression rate of mRNA increased with the development of cervical cancer, the expression is also enhanced. The expression has a certain correlation between the level and development of cervical cancer. Through the above indicators, the development of cervical cancer monitoring and treatment to provide important clinical guidance.
Copyright © 2017 Hainan Medical University. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Human papillomavirus; mRNA expression

Year:  2017        PMID: 28237489     DOI: 10.1016/j.apjtm.2017.01.007

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  4 in total

1.  miR‑218 functions as a tumor suppressor gene in cervical cancer.

Authors:  Zhen Liu; Lin Mao; Linlin Wang; Hong Zhang; Xiaoxia Hu
Journal:  Mol Med Rep       Date:  2019-11-11       Impact factor: 2.952

2.  Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.

Authors:  Yue-Xin Hu; Ming-Jun Zheng; Wen-Chao Zhang; Xiao Li; Rui Gou; Xin Nie; Qing Liu; Ying-Ying Hao; Juan-Juan Liu; Bei Lin
Journal:  J Transl Med       Date:  2019-11-19       Impact factor: 5.531

3.  Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma.

Authors:  Dahai Xu; Chang Su; Liang Guo; He Yan; Shaokun Wang; Congwang Yuan; Guohui Chen; Li Pang; Nan Zhang
Journal:  Open Life Sci       Date:  2019-07-10       Impact factor: 0.938

Review 4.  The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.

Authors:  Giovanni Barillari; Paolo Monini; Cecilia Sgadari; Barbara Ensoli
Journal:  Int J Mol Sci       Date:  2018-05-09       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.